Pro Medicus Ltd
PME
Company Profile
Business description
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.
Contact
450 Swan Street
RichmondVIC3121
AUST: +61 394298800
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
30 June 2025
Employees
75
Stocks News & Analysis
stocks
Should you avoid this highflying ASX share?
A sound business model but the shares are expensive.
personal-finance
Bookworm: A timely reminder of what can drive a market reversal
David Dreman sought to beat the market by going against the crowd. The mechanisms behind that could explain Nvidia's recent fall.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,926.70 | 126.00 | -1.56% |
| CAC 40 | 7,598.98 | 259.85 | -3.31% |
| DAX 40 | 21,717.39 | 673.45 | -3.01% |
| Dow JONES (US) | 40,545.93 | 1,679.39 | -3.98% |
| FTSE 100 | 8,474.74 | 133.74 | -1.55% |
| HKSE | 22,849.81 | 352.72 | -1.52% |
| NASDAQ | 16,550.61 | 1,050.44 | -5.97% |
| Nikkei 225 | 34,148.62 | 587.31 | -1.69% |
| NZX 50 Index | 12,239.26 | 99.31 | -0.80% |
| S&P 500 | 5,396.52 | 274.45 | -4.84% |
| S&P/ASX 200 | 7,741.30 | 118.40 | -1.51% |
| SSE Composite Index | 3,342.01 | 8.12 | -0.24% |